Kuros Biosciences AG (SWX: KURN)
16.98
-0.08 (-0.47%)
Sep 4, 2024, 5:30 PM CET
Kuros Biosciences AG Income Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 365.79 | 576.91 | 623.85 | 414.06 | 333.51 | 385.1 | Upgrade
|
Revenue Growth (YoY) | -44.72% | -7.52% | 50.67% | 24.15% | -13.40% | -2.08% | Upgrade
|
Cost of Revenue | 214.65 | 323.02 | 317.09 | 220.5 | 183.08 | 210.61 | Upgrade
|
Gross Profit | 151.14 | 253.89 | 306.76 | 193.56 | 150.43 | 174.49 | Upgrade
|
Selling, General & Admin | 69.24 | 70.98 | 75.4 | 66.58 | 56.58 | 59.92 | Upgrade
|
Research & Development | 121.01 | 122.71 | 111.57 | 106.17 | 86.21 | 83.61 | Upgrade
|
Other Operating Expenses | -1.78 | -1.84 | -1.98 | -4.2 | -1.67 | -3.73 | Upgrade
|
Operating Expenses | 188.48 | 191.86 | 184.99 | 168.55 | 141.13 | 139.79 | Upgrade
|
Operating Income | -37.34 | 62.03 | 121.78 | 25.01 | 9.31 | 34.7 | Upgrade
|
Interest Expense | - | -1.73 | -2.04 | -2.74 | -3.63 | -2.97 | Upgrade
|
Interest & Investment Income | 13.51 | 2.2 | 0.17 | 0.09 | 0.09 | 0.24 | Upgrade
|
Earnings From Equity Investments | -0.17 | -0.2 | -0.12 | -1.82 | -4.16 | -4.25 | Upgrade
|
Currency Exchange Gain (Loss) | -8.97 | -8.97 | 0.03 | 3.86 | -6.62 | -1.1 | Upgrade
|
Other Non Operating Income (Expenses) | -0.43 | -0.43 | 0.33 | -0.04 | 0.09 | 0.24 | Upgrade
|
EBT Excluding Unusual Items | -33.4 | 52.91 | 120.14 | 24.36 | -4.93 | 26.87 | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | - | -2.6 | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | - | - | - | -1.56 | - | - | Upgrade
|
Asset Writedown | -65.42 | -65.42 | - | -0.07 | -74.12 | -12.65 | Upgrade
|
Other Unusual Items | - | - | - | 0.94 | - | - | Upgrade
|
Pretax Income | -98.82 | -12.51 | 120.14 | 21.08 | -79.05 | 14.22 | Upgrade
|
Income Tax Expense | -18.35 | -3.88 | 18.37 | 5.73 | -14.19 | 1.31 | Upgrade
|
Earnings From Continuing Operations | -80.47 | -8.63 | 101.77 | 15.35 | -64.86 | 12.91 | Upgrade
|
Minority Interest in Earnings | - | - | - | -0.02 | 0.24 | 0.15 | Upgrade
|
Net Income | -80.47 | -8.63 | 101.77 | 15.33 | -64.63 | 13.06 | Upgrade
|
Net Income to Common | -80.47 | -8.63 | 101.77 | 15.33 | -64.63 | 13.06 | Upgrade
|
Net Income Growth | - | - | 563.92% | - | - | -66.06% | Upgrade
|
Shares Outstanding (Basic) | 7 | 7 | 7 | 7 | 7 | 7 | Upgrade
|
Shares Outstanding (Diluted) | 7 | 7 | 7 | 7 | 7 | 7 | Upgrade
|
Shares Change (YoY) | 0.34% | 0.39% | 2.34% | - | 0.19% | 0.01% | Upgrade
|
EPS (Basic) | -11.07 | -1.21 | 14.60 | 2.21 | -9.32 | 1.89 | Upgrade
|
EPS (Diluted) | -11.07 | -1.21 | 14.34 | 2.21 | -9.32 | 1.89 | Upgrade
|
EPS Growth | - | - | 548.93% | - | - | -66.07% | Upgrade
|
Free Cash Flow | 78.11 | 52.04 | 109.48 | 91.5 | 35.17 | 70.8 | Upgrade
|
Free Cash Flow Per Share | 10.74 | 7.30 | 15.42 | 13.19 | 5.07 | 10.23 | Upgrade
|
Dividend Per Share | 1.000 | 1.000 | 2.000 | 1.300 | - | 0.600 | Upgrade
|
Dividend Growth | -50.00% | -50.00% | 53.85% | - | - | -62.50% | Upgrade
|
Gross Margin | 41.32% | 44.01% | 49.17% | 46.75% | 45.11% | 45.31% | Upgrade
|
Operating Margin | -10.21% | 10.75% | 19.52% | 6.04% | 2.79% | 9.01% | Upgrade
|
Profit Margin | -22.00% | -1.50% | 16.31% | 3.70% | -19.38% | 3.39% | Upgrade
|
Free Cash Flow Margin | 21.35% | 9.02% | 17.55% | 22.10% | 10.55% | 18.39% | Upgrade
|
EBITDA | -30.2 | 71.57 | 132.02 | 33.69 | 19.2 | 46.61 | Upgrade
|
EBITDA Margin | -8.26% | 12.40% | 21.16% | 8.14% | 5.76% | 12.10% | Upgrade
|
D&A For EBITDA | 7.15 | 9.53 | 10.24 | 8.68 | 9.89 | 11.91 | Upgrade
|
EBIT | -37.34 | 62.03 | 121.78 | 25.01 | 9.31 | 34.7 | Upgrade
|
EBIT Margin | -10.21% | 10.75% | 19.52% | 6.04% | 2.79% | 9.01% | Upgrade
|
Effective Tax Rate | - | - | 15.29% | 27.16% | - | 9.18% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.